CD4 and disease arising from reactivation of latent virus: To further determine whether TIQ-15 inhibits HIV-1 latent infection of blood resting CD4 T cells, we purified human resting T cells from peripheral blood (98% pure), and pretreated cells with TIQ-15, and then infected cells with HIV-1(NL4-3).